(Q38451253)

3 September 2017

1 reference

title

Are reactive oxygen species still the basis for diabetic complications? (English)

1 reference

Jennifer L Wilkinson-Berka

3 September 2017

reactive oxygen species

1 reference

based on heuristic

inferred from title

author

4

1 reference

3 September 2017

Judy B de Haan

6

0 references

author name string

Elyse Di Marco

1

1 reference

3 September 2017

Jay C Jha

2

1 reference

3 September 2017

Arpeeta Sharma

3

1 reference

3 September 2017

Karin A Jandeleit-Dahm

5

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 July 2015

1 reference

3 September 2017

1 reference

3 September 2017

129

1 reference

3 September 2017

2

1 reference

3 September 2017

199-216

1 reference

Reactive oxygen species in pathogenesis of atherosclerosis

3 September 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

How mitochondria produce reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Oxidative stress and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Lipid peroxidation is increased in paraoxonase L55 homozygotes compared with M-allele carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Dietary cosupplementation with vitamin E and coenzyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Effect of antioxidant vitamin E as a protective factor in experimental atherosclerosis in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Effect of vitamin E on aortic lipid oxidation and intimal proliferation after arterial injury in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Unraveling the truth about antioxidants: mitohormesis explains ROS-induced health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Unraveling the biological roles of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

The ambivalence of vitamin E in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

The immune system in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Diabetes-accelerated atherosclerosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Mechanisms underlying endothelial dysfunction in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Molecular regulation of vascular smooth muscle cell differentiation in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Reactive oxygen species in the vasculature: molecular and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

NADPH oxidases: functions and pathologies in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Superoxide production and expression of nox family proteins in human atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

The Nox family of NADPH oxidases: friend or foe of the vascular system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Upregulation of intermediate-conductance Ca2+-activated K+ channels (KCNN4) in porcine coronary smooth muscle requires NADPH oxidase 5 (NOX5).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Superoxide production by macrophages and T cells is critical for the induction of autoreactivity and type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Loss of NADPH oxidase-derived superoxide skews macrophage phenotypes to delay type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Vascular smooth muscle function in type 2 diabetes mellitus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Reactive oxygen species signaling in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Activation of NADPH oxidase 1 increases intracellular calcium and migration of smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Selective inhibition of NADPH oxidase reverses the over contraction of diabetic rat aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Hyperglycemia and the O-GlcNAc transferase in rat aortic smooth muscle cells: elevated expression and altered patterns of O-GlcNAcylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Protein O-GlcNAcylation and cardiovascular (patho)physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Deep sequencing reveals novel Set7 networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

p66(Shc) protein, oxidative stress, and cardiovascular complications of diabetes: the missing link.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Oxidative stress in vascular disease and its pharmacological prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Pathogenesis, prevention, and treatment of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Molecular understanding of hyperglycemia's adverse effects for diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Oxidative stress as a major culprit in kidney disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Involvement of oxidative stress in the pathogenesis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

NADPH oxidases in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Phosphatidic acid and diacylglycerol directly activate NADPH oxidase by interacting with enzyme components

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Oxidative stress parameters in blood, liver, and kidney of diabetic rats treated with curcumin and/or insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Subcellular localization of Nox4 and regulation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

IGF-I increases the expression of fibronectin by Nox4-dependent Akt phosphorylation in renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Role of Nox4 in murine models of kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Effects of NADPH oxidase inhibitor in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Nrf2 activators as attractive therapeutics for diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Bardoxolone methyl and kidney function in CKD with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Global prevalence and major risk factors of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Micronutrients and diabetic retinopathy a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Role of NADPH oxidase in retinal vascular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Genetic, biochemical, and clinical features of chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Lack of the antioxidant glutathione peroxidase-1 (GPx1) exacerbates retinopathy of prematurity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

NRF2 plays a protective role in diabetic retinopathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Cross talk between mitochondria and NADPH oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

The role of hydrogen peroxide in endothelial proliferative responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Role of hydrogen peroxide in NF-kappaB activation: from inducer to modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Hydrogen peroxide as a damage signal in tissue injury and inflammation: murderer, mediator, or messenger?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Tissue-specific functions of individual glutathione peroxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in japanese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Glutathione peroxidase 1 genotype is associated with an increased risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Effect of acute myocardial infarction on erythrocytic glutathione peroxidase 1 activity and plasma vitamin e levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Comparative and combined effect of chlorogenic acid and tetrahydrocurcumin on antioxidant disparities in chemical induced experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Amelioration of streptozotocin-induced diabetes mellitus, oxidative stress and dyslipidemia in rats by tomato extract lycopene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

No evidence for a major effect of two common polymorphisms of the catalase gene in type 1 diabetes susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

The catalase -262C/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Ebselen augments its peroxidase activity by inducing nrf-2-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Ebselen, a seleno-organic antioxidant, as an electrophile

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Is there a sweet spot for Nrf2 activation in the treatment of diabetic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Late-intervention study with ebselen in an experimental model of type 1 diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Prognostic value of endothelial dysfunction in type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Deficient eNOS phosphorylation is a mechanism for diabetic vascular dysfunction contributing to increased stroke size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Peroxynitrite disrupts endothelial caveolae leading to eNOS uncoupling and diminished flow-mediated dilation in coronary arterioles of diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Challenges with nitrate therapy and nitrate tolerance: prevalence, prevention, and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

A novel biologically active seleno-organic compound—1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20150093

21 January 2018

Identifiers

DOI

10.1042/CS20150093

1 reference

3 September 2017

1 reference